Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.
about
Molecular pathogenesis of pulmonary arterial hypertensionPulmonary hypertension: diagnostic and therapeutic challengesPulmonary Arterial Hypertension and the Sex Hormone Paradox.N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control studyMulticentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocolSex differences in the pulmonary circulation: implications for pulmonary hypertensionKidney dysfunction in patients with pulmonary arterial hypertensionFollow-up tricuspid annular plane systolic excursion predicts survival in pulmonary arterial hypertension.Pulmonary venous occlusion and death in pulmonary arterial hypertension: survival analyses using radiographic surrogates.Metabolic and hormonal derangements in pulmonary hypertension: from mouse to man.Significance of pulmonary arterial pressure as a prognostic indicator in lung-dominant connective tissue disease.Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registryPulmonary hypertension in women.Connective tissue disease-associated pulmonary arterial hypertension.Lung transplantation for pulmonary hypertension.Right ventricular remodeling in idiopathic and scleroderma-associated pulmonary arterial hypertension: two distinct phenotypes.Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction.Three-dimensional analysis of right ventricular shape and function in pulmonary hypertension.Diagnosis and risk stratification in patients with anti-RNP autoimmunity.Where do we go from here? Reappraising the data on anticoagulation in pulmonary arterial hypertension.Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension.Severity of systemic sclerosis-associated pulmonary arterial hypertension in African AmericansExercise training in pulmonary arterial hypertension associated with connective tissue diseasesAmbrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial HypertensionSurvival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.Pulmonary hypertension in parenchymal lung disease.Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension.Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study.Pulmonary hypertension in systemic lupus erythematosus: a systematic review and analysis of 642 cases in Chinese population.Survival outcomes in severe congenital versus non-congenital pulmonary hypertensionLatest advances in connective tissue disorders.Pulmonary arterial hypertension associated with connective tissue disease: meta-analysis of clinical trialsAdverse Events in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature.Association Between Initial Oral Therapy and Outcomes in Systemic Sclerosis-Related Pulmonary Arterial Hypertension.Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients.Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.Exaggerated increase of exercise-induced pulmonary artery pressure in systemic sclerosis patients predominantly results from left ventricular diastolic dysfunction.Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era.
P2860
Q24634317-E82B2042-F863-4A10-B9CE-24F3D0D5AA76Q26796434-35D86B2D-5D20-414C-B5E8-E1D2518A5BDBQ30241478-2988D8EA-ED67-47DB-BA1C-A6FC1858B4E9Q30463476-D1C2451E-8C92-4AB4-8CAE-AAB7E6D04B20Q30490484-A0FC12C0-1BE0-4DC7-AAF5-33D1AE8967E4Q33568826-FD127B68-0FB7-4CC2-BD77-7D162F25FEE5Q33738621-1B6E6781-F7FB-4834-BF42-6DF52D5FA1C2Q33788434-8A9837D9-29AD-4F3C-8E7C-4E944831E990Q34040866-C01796A3-C3F7-4D12-B711-71F341229F28Q34245617-7B8D5248-D671-4230-95C2-E1EF8BE2D902Q34277188-4FC14336-A4A5-4343-B890-C267AB79BDDEQ34609902-2BD89E55-1118-4385-BA23-BB95A8A2D26CQ34795939-1D9B7309-354B-4880-9928-32E72DEFC6D5Q35029607-B1EAC723-44FE-4515-B48A-444D69BC08E0Q35412426-94FAAA1B-1191-464B-A3B4-AC607B6022CBQ35665758-EB8C24AE-4082-4DB6-AB05-53EF7496DED4Q35867030-C34735DF-802A-4C59-8361-A23B23E6ECBDQ35929749-CA2F4FC1-8FC5-47A9-A325-BA90F7004265Q35930490-7CE94049-607A-48E1-97B7-9E6DF92EFB75Q36013002-A754319E-950A-46C6-A0B3-32C62C979823Q36075442-7C3A82FA-E317-4081-BC9F-D842C2CD94BCQ36150934-8BD11230-C190-459D-936F-8F48ED977853Q36246144-D102870A-CD16-4E34-A75D-75E51F546D49Q36272405-A7E4FD80-2C6A-4713-9286-3F83A74168ACQ36272410-614D4CE4-478D-474B-8275-FE0ADA5F8CFEQ36307583-0CA53AB7-CC23-42ED-835F-2571C1060C61Q36328903-8A872660-86EE-4F83-8990-62F3A134BC90Q36490169-62CB40F0-B6EA-4FFE-8676-0F9C3DD809E1Q36633190-6FAA0E31-9DF2-4D1A-AB06-D1C0E83829E9Q36785465-D42CAFDF-0A25-419F-8E07-C5A5695E0139Q36982766-C1389C09-C0F5-408E-94BE-E8E07EE4E42CQ37058776-BEE3EA5F-A686-4513-A961-CAE814C220D7Q37069668-9479CC76-8013-40C9-8693-14CA4E08AD86Q37106203-15D1F972-FD63-4A2F-B1E2-24AD000EA900Q37185564-A93E90B0-1746-4EAC-9AC8-14758B5B21F9Q37200751-08006267-BF11-48E7-B7B1-2DC14C45D0E6Q37206944-75467288-9687-466D-9587-93EFD030A961Q37274520-97514433-5237-4886-87A2-18EB21CC8C1DQ37300997-5018190A-4F9C-42C9-BDB7-5C4576E8265AQ37345940-CE7A6FA2-08E2-4FB0-A3C0-7E78E1F4010F
P2860
Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Characterization of connective ...... lerosis as a unique phenotype.
@en
type
label
Characterization of connective ...... lerosis as a unique phenotype.
@en
prefLabel
Characterization of connective ...... lerosis as a unique phenotype.
@en
P2093
P2860
P356
P1433
P1476
Characterization of connective ...... lerosis as a unique phenotype.
@en
P2093
Dave P Miller
David B Badesch
Juliana Liu
Lori Parsons
Lorinda Chung
Mark R Nicolls
Michael McGoon
Paul M Hassoun
Roham T Zamanian
P2860
P304
P356
10.1378/CHEST.10-0260
P407
P577
2010-05-27T00:00:00Z